Jafri Mikram, Sachdev Amit, Sadiq Javed, Lee David, Taur Ting, Goodman Adam, Gress Frank
Albany Stratton VA Medical Center, USA.
Columbia University Medical Center, USA.
JOP. 2017 Mar;18(2):125-132. Epub 2017 Mar 30.
Endotherapy is a treatment modality that can be used to manage the pain associated with chronic pancreatitis. The aim of this systematic review and meta-analysis is to evaluate the efficacy of endotherapy in the management of pain associated with chronic pancreatitis.
A search of Medline, Pubmed, and Embase databases between 1988 to December 2014 was conducted to evaluate the use of endotherapy for pain relief in patients with chronic pancreatitis. We included large prospective studies, randomized controlled trials and retrospective analyses. Exclusion criteria included studies not written in the English language, small studies with less than 10 patients, case series/case reports and studies that enrolled patients treated with dual therapies including surgery or celiac plexus neurolysis. In addition, a subgroup analysis was conducted to evaluate studies that included patients with pancreatic duct strictures. A meta-analysis was performed and the data on pain relief was subsequently extracted, pooled, and analyzed. I index estimates were calculated to test for variability and heterogeneity across the included studies.
Our final analysis included sixteen studies, comprising 1498 patients. Eleven studies presented data on immediate pain relief after endotherapy and twelve studies presented data on both immediate and long term pain relief (mean follow up was 47.4 months). The compiled result of the sixteen studies for immediate pain relief demonstrated 88% efficacy (95% NT CI [81.0%, 94%]) of endotherapy. Similarly, analysis of pain relief on long term follow-up showed a 67% efficacy of endotherapy (95% NT CI [58%, 76%]). The compiled complication rate for endotherapy in this review was 7.85% per ERCP/endotherapeutic procedure and the most common complications were acute pancreatitis, stent occlusion and stent migration.
Endotherapy is beneficial for both immediate and long term management of pain associated with chronic pancreatitis. The efficacy of endotherapy decreases over time as assessed by evaluating pain relief on long term follow up. Given the considerable heterogeneity of reported data, additional prospective and standardized multicenter studies need to be conducted to evaluate the efficacy of this modality in controlling pain associated with chronic pancreatitis.
内镜治疗是一种可用于治疗慢性胰腺炎相关疼痛的治疗方式。本系统评价和荟萃分析的目的是评估内镜治疗在慢性胰腺炎相关疼痛管理中的疗效。
检索了1988年至2014年12月期间的Medline、Pubmed和Embase数据库,以评估内镜治疗在慢性胰腺炎患者疼痛缓解中的应用。我们纳入了大型前瞻性研究、随机对照试验和回顾性分析。排除标准包括非英文撰写的研究、患者少于10例的小型研究、病例系列/病例报告以及纳入接受包括手术或腹腔神经丛神经松解术在内的双重治疗患者的研究。此外,进行了亚组分析以评估纳入胰腺导管狭窄患者的研究。进行了荟萃分析,随后提取、汇总并分析了疼痛缓解数据。计算I指数估计值以检验纳入研究之间的变异性和异质性。
我们的最终分析纳入了16项研究,共1498例患者。11项研究提供了内镜治疗后即时疼痛缓解的数据,12项研究提供了即时和长期疼痛缓解的数据(平均随访47.4个月)。16项研究即时疼痛缓解的汇总结果显示内镜治疗的有效率为88%(95%非参数置信区间[81.0%,94%])。同样地,长期随访疼痛缓解分析显示内镜治疗的有效率为67%(95%非参数置信区间[58%,76%])。本综述中内镜治疗的汇总并发症发生率为每次内镜逆行胰胆管造影术/内镜治疗操作7.85%,最常见的并发症是急性胰腺炎、支架阻塞和支架移位。
内镜治疗对慢性胰腺炎相关疼痛的即时和长期管理均有益。通过长期随访评估疼痛缓解情况可知,内镜治疗的疗效会随时间下降。鉴于报告数据存在相当大的异质性,需要开展更多前瞻性和标准化的多中心研究来评估这种治疗方式在控制慢性胰腺炎相关疼痛方面的疗效。